Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022
/in Press Releases /by davidGlympse Appoints Jonathan Wilde, Ph.D., as Chief Scientific Officer to Advance Biosensor Assay Platform
/in Press Releases /by davidGlympse to Present Dataset Demonstrating Liquid Biopsy Approach to Predict NASH at AASLD’s The Liver Meeting
/in Press Releases /by davidGlympse to Present Data from First Application of New Liquid Biopsy Diagnostic Platform at AASLD’s The Liver Meeting 2021
/in Press Releases /by davidGlympse Bio Appoints Matthew T. Navarro, J.D., as Chief Financial Officer
/in Press Releases /by raincastleGlympse Bio Names Jessica Atkinson Senior Vice President of Business Development
/in Press Releases /by raincastleFirst-In-Human Data Supporting the Safety of Glympse Bio’s Biosensors are Presented at the AASLD 2020 Annual Meeting
/in Press Releases /by raincastleGlympse Bio to Present Clinical Data at the AASLD 2020 Annual Meeting
/in Press Releases /by raincastle35 Cambridgepark Drive
Suite 100
Cambridge, MA 02140
© 2022 Glympse Bio. All rights reserved.
Terms of Use | Privacy Policy | Other Policies
Design and development by RainCastle Communications.
Images by Liz Linder Photography.